国际标准期刊号: 2576-3881

细胞因子生物学杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

ORF3a mutations: an adaptive advantage for SARS-CoV-2 pathogenecity

Sougata Niyogi , Parinita Majumdar

The outbreak of severe acute respiratory syndrome in November 2019 resulted in a global public health emergency which warrants investigation of the virulence and pathogenecity of SARS-CoV-2. The reasonably higher mutation rate in SARS-CoV-2 led to the emergence of its numerous genetic variants which is likely to be responsible for COVID-19 associated morbidity and mortality. Mutations in ORF3a protein could modulate viral pathogenecity by interfering with host immune response and apoptotic pathways.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。